Reaching the london declaration on neglected tropical diseases goals for onchocerciasis: an economic evaluation of increasing the frequency of ivermectin treatment in Africa.
about
The Onchocerciasis Vaccine for Africa--TOVA--InitiativeOnchocerciasis transmission in Ghana: the human blood index of sibling species of the Simulium damnosum complex.Comparison of Doxycycline, Minocycline, Doxycycline plus Albendazole and Albendazole Alone in Their Efficacy against Onchocerciasis in a Randomized, Open-Label, Pilot TrialHuman Onchocerciasis: Modelling the Potential Long-term Consequences of a Vaccination ProgrammeIdentification of Ecdysone Hormone Receptor Agonists as a Therapeutic Approach for Treating Filarial InfectionsDoes Increasing Treatment Frequency Address Suboptimal Responses to Ivermectin for the Control and Elimination of River Blindness?Increased mortality attributed to Chagas disease: a systematic review and meta-analysis.Possible changes in the transmissibility of trachoma following MDA and transmission reduction: implications for the GET2020 goals.The potential impact of moxidectin on onchocerciasis elimination in Africa: an economic evaluation based on the Phase II clinical trial dataThe role of 'omics' in the quest to eliminate human filariasis.A murine macrofilaricide pre-clinical screening model for onchocerciasis and lymphatic filariasisOnchocerciasis transmission in Ghana: persistence under different control strategies and the role of the simuliid vectors.Model-Based Geostatistical Mapping of the Prevalence of Onchocerca volvulus in West AfricaDoxycycline Leads to Sterility and Enhanced Killing of Female Onchocerca volvulus Worms in an Area With Persistent Microfilaridermia After Repeated Ivermectin Treatment: A Randomized, Placebo-Controlled, Double-Blind TrialRequired duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis.Estimation of changes in the force of infection for intestinal and urogenital schistosomiasis in countries with schistosomiasis control initiative-assisted programmes.Modelling Anti-Ov16 IgG4 Antibody Prevalence as an Indicator for Evaluation and Decision Making in Onchocerciasis Elimination Programmes.Modelling the elimination of river blindness using long-term epidemiological and programmatic data from Mali and Senegal.Quantitative analyses and modelling to support achievement of the 2020 goals for nine neglected tropical diseases.Profiling Nonrecipients of Mass Drug Administration for Schistosomiasis and Hookworm Infections: A Comprehensive Analysis of Praziquantel and Albendazole Coverage in Community-Directed Treatment in UgandaEvidence of suppression of onchocerciasis transmission in the Venezuelan Amazonian focus.Compliance with anthelmintic treatment in the neglected tropical diseases control programmes: a systematic review.Modelling Neglected Tropical Diseases diagnostics: the sensitivity of skin snips for Onchocerca volvulus in near elimination and surveillance settings.Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results.Phenotypic and molecular analysis of the effect of 20-hydroxyecdysone on the human filarial parasite Brugia malayiAnalysis of the population-level impact of co-administering ivermectin with albendazole or mebendazole for the control and elimination of Trichuris trichiura.Assessment of the scope and practice of evaluation among medical donation programs.The genome of Onchocerca volvulus, agent of river blindness.Measuring and modelling the effects of systematic non-adherence to mass drug administration.Genome-wide analysis of ivermectin response by Onchocerca volvulus reveals that genetic drift and soft selective sweeps contribute to loss of drug sensitivity.Macrofilaricidal Efficacy of Repeated Doses of Ivermectin for the Treatment of River Blindness.Nobel prize for the artemisinin and ivermectin discoveries: a great boost towards elimination of the global infectious diseases of poverty.Economic evaluations of lymphatic filariasis interventions: a systematic review and research needs.Economic evaluations of mass drug administration: The importance of economies of scale and scope.From river blindness control to elimination: bridge over troubled water.Comparison of PCR Methods for Onchocerca volvulus Detection in Skin Snip Biopsies from the Tshopo Province, Democratic Republic of the Congo.Onchocerca volvulus infection and serological prevalence, ocular onchocerciasis and parasite transmission in northern and central Togo after decades of Simulium damnosum s.l. vector control and mass drug administration of ivermectin.Modelling the impact of larviciding on the population dynamics and biting rates of Simulium damnosum (s.l.): implications for vector control as a complementary strategy for onchocerciasis elimination in Africa.
P2860
Q21562329-548626FE-20EB-40B1-AB02-83793160E00AQ26315231-500348A4-E337-4A4D-BDCD-BB13CAA1BA92Q28468411-E5C2DBE0-D07A-4F87-8CE2-A5F90E5917B9Q28546650-64F4BCA9-351D-4AEF-975D-62430C546F75Q28550257-AB8AF29E-D52D-48E5-A473-19BEBE74356FQ28602538-B39CD3BB-C80C-4D86-B444-ADF8F70926AEQ30383896-CF3B88EA-446D-4A67-9C8F-371C612E9549Q30670495-C431B26A-1392-4558-8E5E-48C094580BA1Q30936469-ADE9D50A-5E40-4D54-BEBF-697F2B948BBBQ33584584-3F13E397-DFC6-4A58-A69E-FFB7E40C155CQ34416898-1940B537-C3DA-4BB4-BD07-D82719F40656Q35510635-B20668A6-6C51-4C77-9E6E-827063CD0726Q35895175-B2F89477-218D-49C3-9FAE-4097D0B9273DQ35898029-255A8BC0-D178-4699-8776-D05AE72F0D6AQ36201881-9ADDC0B1-0798-48FB-B3FD-E7E33EEF4B1DQ36204615-5155C619-ED88-4B11-BD16-674461227F6BQ36257358-9F3833E9-E9D1-4590-8CBA-E3C25C67767AQ36303283-22CD0E5E-A224-430A-8B7B-267CEB95D8CEQ36361450-204F2933-EBA7-4CFB-8047-16EBB94B9696Q36402476-831F06D1-333C-4197-A5DC-08830C52BA5EQ36507933-AB194552-3214-4680-A801-FD9A4722FFEEQ36508829-625EDF3E-EB75-4977-968F-E40EEA474186Q37006791-792E350C-171C-44E0-8739-F31BB86EF9F3Q37045287-D33C071A-7643-4483-855C-E196EFA000E0Q37074803-EECC90BF-FF11-4475-B16F-EB609B424674Q37096983-B2B7CACC-E570-403E-8728-EF0EE2851FD8Q37394764-96FF82AD-2373-4E27-A97E-3B7349430F3DQ37643713-E42EC215-9A8E-4BEF-BA8D-080E80EF9D84Q38916889-A0E8EEEF-3415-461A-83A4-2DFB4CFDB6CDQ38977668-1D0219C2-3D52-466C-BF8A-8DD10152F44BQ41987224-74E1C046-E3E7-415E-84D5-D486BF98C519Q43115498-07FA3CC4-5D1F-4ACC-9582-07E66614CDCBQ47553077-D470A85B-ED46-46C6-86D2-C4EB6E8A95F9Q47612597-B79EDB01-0A63-4397-8877-DA83BBD2C915Q52627211-284F7D01-3552-46EF-835E-070318355677Q53696431-3EAA4FF9-4514-48F7-800E-1F5EA1B2571EQ53701529-E286EFD9-2CCD-47FC-93A2-F05C5171DBBFQ55401692-C49D7F7D-3C78-4B5F-9588-5EA1A3A0853B
P2860
Reaching the london declaration on neglected tropical diseases goals for onchocerciasis: an economic evaluation of increasing the frequency of ivermectin treatment in Africa.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Reaching the london declaratio ...... vermectin treatment in Africa.
@ast
Reaching the london declaratio ...... vermectin treatment in Africa.
@en
Reaching the london declaratio ...... vermectin treatment in Africa.
@nl
type
label
Reaching the london declaratio ...... vermectin treatment in Africa.
@ast
Reaching the london declaratio ...... vermectin treatment in Africa.
@en
Reaching the london declaratio ...... vermectin treatment in Africa.
@nl
prefLabel
Reaching the london declaratio ...... vermectin treatment in Africa.
@ast
Reaching the london declaratio ...... vermectin treatment in Africa.
@en
Reaching the london declaratio ...... vermectin treatment in Africa.
@nl
P2093
P2860
P50
P356
P1476
Reaching the london declaratio ...... vermectin treatment in Africa.
@en
P2093
Adrian Hopkins
Mike Y Osei-Atweneboana
Roger K Prichard
P2860
P304
P356
10.1093/CID/CIU467
P407
P577
2014-06-18T00:00:00Z